Hemostatic drugs

N Engl J Med. 1998 Jul 23;339(4):245-53. doi: 10.1056/NEJM199807233390407.
No abstract available

Publication types

  • Review

MeSH terms

  • Aminocaproates / adverse effects
  • Aminocaproates / therapeutic use
  • Antifibrinolytic Agents / adverse effects
  • Antifibrinolytic Agents / therapeutic use*
  • Aprotinin / adverse effects
  • Aprotinin / therapeutic use*
  • Blood Coagulation Disorders / congenital
  • Blood Coagulation Disorders / drug therapy
  • Blood Loss, Surgical / prevention & control
  • Cardiac Surgical Procedures
  • Deamino Arginine Vasopressin / adverse effects
  • Deamino Arginine Vasopressin / therapeutic use*
  • Estrogens, Conjugated (USP) / therapeutic use*
  • Hemorrhage / drug therapy*
  • Hemostatics / adverse effects
  • Hemostatics / therapeutic use*
  • Humans
  • Liver Transplantation
  • Tranexamic Acid / adverse effects
  • Tranexamic Acid / therapeutic use

Substances

  • Aminocaproates
  • Antifibrinolytic Agents
  • Estrogens, Conjugated (USP)
  • Hemostatics
  • Tranexamic Acid
  • Aprotinin
  • Deamino Arginine Vasopressin